pharma · Opioid Use Disorder · Opioid Dependence
Indivior Pty
Indivior Pty Ltd
Indivior Pty clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- ., Richmond, VA, US
- Employees
- 967
- Programs
- 39
- Drugs
- 19
- Patents
- 34
Indivior Pty projects
6 ClinicalTrials.gov programs sponsored by Indivior Pty.
Indivior Pty has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Intranasal challenge drug
Indivior Pty Ltd
Heroin Dependence
1 trial -
RBP-6000
Indivior Pty Ltd
Opioid Use Disorder
4 trials -
RBP-7000
Indivior Pty Ltd
Schizophrenia
5 trials -
SUBLOCADE
Indivior Pty Ltd
Opioid Use Disorder
2 trials -
SUBOXONE
Indivior Pty Ltd
Opioid Dependence
1 trial -
SUBOXONE sublingual film
Indivior Pty Ltd
Opioid Use Disorder
1 trial
Frequently asked questions
How many clinical projects does Indivior Pty have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.